Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Probiotics  COVID-19 treatment studies for Probiotics  C19 studies: Probiotics  Probiotics   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Time to viral- 29% Improvement Relative Risk Veterini et al. Probiotics for COVID-19 EARLY Is early treatment with probiotics beneficial for COVID-19? Retrospective 30 patients in Indonesia Faster viral clearance with probiotics (not stat. sig., p=0.22) Veterini et al., Indian J. Forensic Medicine & Toxicology, 15:2 Favors probiotics Favors control
Probiotics Intake as Adjunct Therapy for Infected Health-Care with SARS COV-2
Veterini et al., Indian Journal of Forensic Medicine & Toxicology, 15:2
Veterini et al., Probiotics Intake as Adjunct Therapy for Infected Health-Care with SARS COV-2, Indian Journal of Forensic Medicine & Toxicology, 15:2
Jun 2021   Source   PDF  
  All Studies   Meta
Small case control analysis with 15 probiotics patients and 15 contol patients, showing no significant differences. PCR tests were only done weekly. Dosage is unknown. 115/LOE/301.4.2/IX/2020.
The immune effects of probiotics are strain-specific. This study is excluded in the after exclusion results of meta analysis: the observered difference in duration could be caused by the baseline difference in Ct values.
time to viral-, 29.0% lower, relative time 0.71, p = 0.22, treatment 15, control 15.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Veterini et al., 30 Jun 2021, retrospective, Indonesia, peer-reviewed, 6 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperProbioticsAll
Abstract: Indian Journal of Forensic Medicine & Toxicology, April-June 2021, Vol. 15, No. 2 4021 Probiotics Intake as Adjunct Therapy for Infected Health-Care with SARS COV-2 Anna Surgean Veterini1, Eighty Mardiyan Kurniawati2, Hamzah3, Subijanto Marto Soedarmo4, Cita Rosita Sigit Prakoeswa5, Damayanti Tinduh6 1Anesthesiologist Intensivist, 2Obstetrician, 3Anesthesiologist Intensivist, 4Prof., Pediatrician, 5 Prof. Dermatologist, 6Medical Rehabilition Specialist of Dr Soetomo General Academic Hospital – Universitas Airlangga, Address: Jalan Prof. Dr. Moestopo 6-8 Surabaya, Indonesia Abstract Objectives: We performed this case-control observational study to evaluate the comparison of the length of duration of SARS COV-2 infection and the cycle threshold (Ct) value of reverse-transcriptase polymerase chain reaction (RT-PCR) nasopharynx swab between the probiotics intake (case) group and the nonprobiotics intake (control) group. Materials and Methods: Our study was a case-control study involving 15 cases and 15 controls match for RT-PCR positive results. The participants were healthcare consisted of registrars, consultants, and nurses. Each participant was interviewed by google forms using a structured questionnaire to collect sociodemographic characteristics, diet, therapy from a pulmonologist, and adjunct therapy. Results: The total participants consisted of 15 males and 15 females. 4 participants in the case group had febrile, 1 participant with anosmia, 1 participant with febrile, nausea, and vomit before they consumed probiotics, and 9 participants without clinical complaints. One participant in the control group had fevered and cough, 14 participants without clinical complaints—1 participant with co-morbidities in the control group. The data of age, duration of infection, and cycle threshold (Ct) value were in the normal distribution. Analysis results using SPSS 21.00 show no significant differences in the course of disease between the case group and the control group. We found 2 participants in the control group had re-infection, while there was no re-infection in the case group. Conclusion: The present study’s finding may imply future care for the viral infection through the immunomodulation mechanism by probiotics consumption. Keywords: Probiotics; Immunomodulator; COVID-19
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop